Internal Medicine Alert - December 30, 2009

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/09. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Joseph E. Scherger, MD, MPH
Clinical Professor
University of California
San Diego

Rahul Gupta, MD, MPH, FACP
Assistant Professor, Department of Medicine
Meharry Medical College;
Assistant Clinical Professor, Division of General Internal Medicine and Public Health
Vanderbilt University School of Medicine
Nashville, TN

Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine
UCLA School of Medicine

William T. Elliott, MD, FACP

Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Author
Michael H. Crawford, MD
Professor of Medicine, Chief of Clinical Cardiology
University of California
San Francisco

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • Is Low Carb a Bad Mood Diet?
  • Drug Compliance and Persistence — A Major Public Health Problem
  • Planning for the 2009 H1N1 Influenza Pandemic — Are Our Hospitals Ready?
  • Influenza H1N1 Can Hurt Muscles Bad
  • Pharmacology Update: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Cervarix™)
  • Clinical Briefs By Louis Kuritzky, MD

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, is a consultant for Amylin, Cephalon, Novo Nordisk, Sciele, and Takeda; he receives grant/research support and serves on the speakers bureau of Cephalon and Novo Nordisk. Associate editors Joseph E. Scherger, MD, MPH, Harold L. Karpman, MD, FACC, FACP, Rahul Gupta, MD, MPH, FACP, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Associate editor Eileen C. West, MD serves on the speakers bureau for Novartis. Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim. Author Joseph F. John, MD, is a consultant for Cubist, Genzyme, and bioMerieux, and is on the speakers bureau for Cubist, GSK, Merck, Bayer, and Wyeth.

Copyright 2009 AHC Media. All rights reserved.